Compass Therapeutics (CMPX) PT Raised to $13 at Canaccord Genuity
Tweet Send to a Friend
(Updated - February 4, 2026 6:27 AM EST)
Canaccord Genuity analyst John Newman raised the price target on Compass ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst John Newman raised the price target on Compass ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
